Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Syndecan-1 | 37 | 2021 | 165 | 7.600 |
Why?
|
Heparan Sulfate Proteoglycans | 9 | 2022 | 118 | 1.920 |
Why?
|
Proteoglycans | 13 | 2012 | 837 | 1.590 |
Why?
|
Syndecans | 14 | 2017 | 79 | 1.370 |
Why?
|
Glycosaminoglycans | 4 | 2018 | 624 | 1.260 |
Why?
|
Neutrophils | 13 | 2020 | 3721 | 1.220 |
Why?
|
Staphylococcus aureus | 12 | 2015 | 1453 | 1.180 |
Why?
|
Heparitin Sulfate | 12 | 2022 | 225 | 1.090 |
Why?
|
Cell Membrane | 9 | 2022 | 3749 | 0.940 |
Why?
|
Host-Pathogen Interactions | 5 | 2020 | 1480 | 0.880 |
Why?
|
Hemolysin Proteins | 3 | 2009 | 113 | 0.880 |
Why?
|
Bacterial Infections | 3 | 2022 | 1401 | 0.800 |
Why?
|
Streptococcus pneumoniae | 3 | 2020 | 714 | 0.770 |
Why?
|
Listeriosis | 1 | 2020 | 149 | 0.680 |
Why?
|
Communicable Diseases | 3 | 2015 | 880 | 0.660 |
Why?
|
Pneumonia, Staphylococcal | 2 | 2009 | 43 | 0.650 |
Why?
|
Listeria monocytogenes | 1 | 2020 | 250 | 0.630 |
Why?
|
Chemokines, CXC | 4 | 2009 | 422 | 0.620 |
Why?
|
Keratitis | 1 | 2020 | 268 | 0.600 |
Why?
|
Chromatography, Affinity | 3 | 2017 | 549 | 0.600 |
Why?
|
Metalloendopeptidases | 4 | 2018 | 396 | 0.590 |
Why?
|
Fibronectins | 2 | 2020 | 726 | 0.590 |
Why?
|
Bacterial Toxins | 3 | 2009 | 931 | 0.590 |
Why?
|
Elastin | 9 | 2004 | 308 | 0.580 |
Why?
|
Membrane Glycoproteins | 11 | 2006 | 3771 | 0.570 |
Why?
|
Glycomics | 1 | 2018 | 123 | 0.570 |
Why?
|
Sphingomyelin Phosphodiesterase | 2 | 2009 | 91 | 0.550 |
Why?
|
Corneal Diseases | 2 | 2015 | 636 | 0.550 |
Why?
|
Lung Diseases | 4 | 2018 | 1887 | 0.520 |
Why?
|
Shock, Hemorrhagic | 5 | 2017 | 220 | 0.520 |
Why?
|
Cathelicidins | 1 | 2015 | 80 | 0.510 |
Why?
|
Extracellular Matrix | 3 | 2020 | 1741 | 0.490 |
Why?
|
Acetaminophen | 2 | 2020 | 545 | 0.490 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2017 | 366 | 0.480 |
Why?
|
Virulence Factors | 2 | 2009 | 509 | 0.470 |
Why?
|
Mice, Knockout | 20 | 2020 | 14561 | 0.410 |
Why?
|
Animals | 62 | 2022 | 168768 | 0.400 |
Why?
|
Staphylococcal Infections | 3 | 2015 | 1400 | 0.390 |
Why?
|
Pseudomonas aeruginosa | 6 | 2015 | 1219 | 0.380 |
Why?
|
Protein Structure, Tertiary | 9 | 2015 | 3848 | 0.360 |
Why?
|
Mice | 36 | 2022 | 81201 | 0.360 |
Why?
|
Mice, Inbred BALB C | 8 | 2021 | 6386 | 0.350 |
Why?
|
Plasma | 4 | 2017 | 575 | 0.330 |
Why?
|
rab5 GTP-Binding Proteins | 1 | 2008 | 50 | 0.330 |
Why?
|
Virulence | 6 | 2018 | 1333 | 0.330 |
Why?
|
Endotoxemia | 1 | 2009 | 207 | 0.310 |
Why?
|
Lung Injury | 2 | 2009 | 436 | 0.290 |
Why?
|
Receptors, Cell Surface | 5 | 2001 | 2865 | 0.290 |
Why?
|
Neutrophil Infiltration | 2 | 2008 | 391 | 0.290 |
Why?
|
Enterotoxins | 1 | 2008 | 368 | 0.280 |
Why?
|
Bacterial Adhesion | 3 | 2020 | 316 | 0.270 |
Why?
|
Inflammation | 6 | 2018 | 10637 | 0.260 |
Why?
|
Viruses | 1 | 2008 | 375 | 0.250 |
Why?
|
Interleukin-17 | 3 | 2021 | 901 | 0.250 |
Why?
|
Mice, Inbred C57BL | 16 | 2021 | 21833 | 0.250 |
Why?
|
Signal Transduction | 8 | 2022 | 23404 | 0.240 |
Why?
|
Pseudomonas Infections | 4 | 2015 | 613 | 0.220 |
Why?
|
Antimicrobial Cationic Peptides | 2 | 2015 | 362 | 0.220 |
Why?
|
Adhesins, Bacterial | 2 | 2018 | 119 | 0.210 |
Why?
|
Hepatocytes | 2 | 2020 | 1211 | 0.210 |
Why?
|
Epithelial Cells | 6 | 2017 | 3690 | 0.200 |
Why?
|
Shock, Septic | 1 | 2008 | 775 | 0.200 |
Why?
|
Glycocalyx | 2 | 2013 | 88 | 0.190 |
Why?
|
Matrix Metalloproteinase 7 | 2 | 2016 | 58 | 0.190 |
Why?
|
Endothelium | 3 | 2013 | 778 | 0.190 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2021 | 140 | 0.190 |
Why?
|
Blast Crisis | 1 | 2020 | 103 | 0.180 |
Why?
|
Lung | 8 | 2018 | 9857 | 0.180 |
Why?
|
Culture Media, Conditioned | 2 | 2017 | 537 | 0.180 |
Why?
|
Cornea | 2 | 2020 | 1524 | 0.180 |
Why?
|
Streptococcus suis | 1 | 2018 | 6 | 0.170 |
Why?
|
Intestinal Diseases | 2 | 2015 | 530 | 0.170 |
Why?
|
Resuscitation | 3 | 2017 | 658 | 0.170 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2022 | 1677 | 0.170 |
Why?
|
Ligands | 3 | 2022 | 3282 | 0.160 |
Why?
|
Oligosaccharides | 1 | 2000 | 414 | 0.160 |
Why?
|
Liver Failure, Acute | 1 | 2020 | 165 | 0.160 |
Why?
|
Transforming Growth Factor beta | 1 | 2006 | 2007 | 0.160 |
Why?
|
Natural Killer T-Cells | 1 | 2021 | 316 | 0.160 |
Why?
|
Disease Models, Animal | 7 | 2022 | 18034 | 0.160 |
Why?
|
Bacteria | 1 | 2008 | 2115 | 0.150 |
Why?
|
Chondroitin Sulfates | 1 | 2017 | 187 | 0.150 |
Why?
|
Syndecan-4 | 2 | 2015 | 44 | 0.150 |
Why?
|
Recombinant Proteins | 6 | 2009 | 6621 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2018 | 343 | 0.140 |
Why?
|
Blood-Borne Pathogens | 1 | 2016 | 52 | 0.140 |
Why?
|
Chemokine CXCL1 | 1 | 2016 | 101 | 0.140 |
Why?
|
Dermatitis | 1 | 2018 | 199 | 0.140 |
Why?
|
Fluorescent Antibody Technique | 1 | 2020 | 2505 | 0.140 |
Why?
|
Urogenital System | 1 | 2016 | 86 | 0.140 |
Why?
|
Pancreatic Elastase | 1 | 1996 | 136 | 0.140 |
Why?
|
Muramidase | 1 | 1996 | 174 | 0.140 |
Why?
|
Bone Diseases, Developmental | 1 | 2017 | 130 | 0.140 |
Why?
|
Eye Infections | 1 | 2016 | 64 | 0.130 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2017 | 171 | 0.130 |
Why?
|
Neutrophil Activation | 1 | 2016 | 186 | 0.130 |
Why?
|
Lysostaphin | 1 | 1995 | 3 | 0.130 |
Why?
|
Chemokines | 4 | 2011 | 970 | 0.130 |
Why?
|
Plasma Cells | 2 | 2017 | 591 | 0.130 |
Why?
|
Administration, Intranasal | 2 | 2015 | 446 | 0.130 |
Why?
|
TRPC Cation Channels | 1 | 2015 | 121 | 0.130 |
Why?
|
Intestinal Mucosa | 4 | 2016 | 3037 | 0.130 |
Why?
|
Bacterial Proteins | 4 | 2004 | 3854 | 0.130 |
Why?
|
Extracellular Space | 2 | 2010 | 595 | 0.120 |
Why?
|
Membrane Proteins | 2 | 2010 | 7882 | 0.110 |
Why?
|
Microbial Viability | 1 | 2015 | 234 | 0.110 |
Why?
|
Tuberculosis, Gastrointestinal | 1 | 2013 | 20 | 0.110 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2017 | 547 | 0.110 |
Why?
|
Cell Differentiation | 3 | 2021 | 11486 | 0.110 |
Why?
|
Venules | 1 | 2013 | 165 | 0.110 |
Why?
|
Neoplastic Stem Cells | 1 | 2020 | 1376 | 0.110 |
Why?
|
Endothelial Cells | 2 | 2017 | 3486 | 0.110 |
Why?
|
Genes, Bacterial | 1 | 1996 | 1079 | 0.110 |
Why?
|
Cytosol | 1 | 2015 | 901 | 0.100 |
Why?
|
Sepsis | 2 | 2022 | 2593 | 0.100 |
Why?
|
Glucuronidase | 1 | 2013 | 207 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 1903 | 0.100 |
Why?
|
Psoriasis | 1 | 2018 | 902 | 0.090 |
Why?
|
Gene Expression | 2 | 2020 | 7798 | 0.090 |
Why?
|
Chemokine CXCL2 | 1 | 2009 | 115 | 0.090 |
Why?
|
Glutamine | 1 | 2012 | 579 | 0.080 |
Why?
|
Immunohistochemistry | 3 | 2020 | 11366 | 0.080 |
Why?
|
Gene Deletion | 3 | 2006 | 2751 | 0.080 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2011 | 472 | 0.080 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2015 | 852 | 0.080 |
Why?
|
Microbial Sensitivity Tests | 1 | 2015 | 1877 | 0.080 |
Why?
|
Cells, Cultured | 5 | 2017 | 19233 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2017 | 2504 | 0.080 |
Why?
|
Respiratory Tract Infections | 1 | 2016 | 961 | 0.080 |
Why?
|
Protein Binding | 5 | 2008 | 9384 | 0.080 |
Why?
|
Inflammation Mediators | 2 | 2009 | 1888 | 0.080 |
Why?
|
Developmental Disabilities | 1 | 2017 | 1456 | 0.080 |
Why?
|
Collagenases | 1 | 2008 | 228 | 0.080 |
Why?
|
Protein-Losing Enteropathies | 1 | 2008 | 44 | 0.080 |
Why?
|
Respiratory Burst | 1 | 2008 | 114 | 0.080 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2011 | 638 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2016 | 1170 | 0.080 |
Why?
|
Lactoferrin | 1 | 2008 | 97 | 0.080 |
Why?
|
Skin Diseases | 1 | 2016 | 1066 | 0.080 |
Why?
|
Heparin | 2 | 2008 | 1637 | 0.080 |
Why?
|
Cell Movement | 3 | 2016 | 5218 | 0.070 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2007 | 768 | 0.070 |
Why?
|
Humans | 28 | 2020 | 744366 | 0.070 |
Why?
|
Kinetics | 4 | 2003 | 6476 | 0.070 |
Why?
|
Caenorhabditis elegans | 1 | 2015 | 1418 | 0.070 |
Why?
|
Binding Sites | 3 | 2003 | 6111 | 0.070 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10183 | 0.070 |
Why?
|
Trichinella spiralis | 1 | 2006 | 28 | 0.070 |
Why?
|
Pneumococcal Infections | 1 | 2011 | 497 | 0.070 |
Why?
|
Trichinellosis | 1 | 2006 | 36 | 0.070 |
Why?
|
Mutation | 3 | 2018 | 29786 | 0.070 |
Why?
|
Phosphorylation | 2 | 2008 | 8436 | 0.070 |
Why?
|
Parasites | 1 | 2008 | 163 | 0.070 |
Why?
|
Blotting, Western | 5 | 2013 | 5181 | 0.070 |
Why?
|
Molecular Sequence Data | 7 | 2005 | 18111 | 0.070 |
Why?
|
Amino Acid Sequence | 6 | 2005 | 13814 | 0.070 |
Why?
|
Cytokines | 6 | 2016 | 7323 | 0.070 |
Why?
|
Apoptosis | 3 | 2017 | 9724 | 0.070 |
Why?
|
Reperfusion Injury | 1 | 2012 | 1026 | 0.070 |
Why?
|
Muscle Cells | 1 | 2006 | 197 | 0.060 |
Why?
|
Tropoelastin | 3 | 2001 | 29 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3524 | 0.060 |
Why?
|
Protamines | 1 | 2005 | 106 | 0.060 |
Why?
|
Pneumonia | 2 | 2013 | 2133 | 0.060 |
Why?
|
Nephritis, Interstitial | 1 | 2005 | 154 | 0.060 |
Why?
|
Colitis, Ulcerative | 1 | 2016 | 1911 | 0.060 |
Why?
|
Mice, Transgenic | 3 | 2020 | 9735 | 0.060 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 491 | 0.060 |
Why?
|
Sheep | 1 | 2006 | 1437 | 0.060 |
Why?
|
Burns | 2 | 2005 | 1815 | 0.060 |
Why?
|
Respiratory Hypersensitivity | 1 | 2005 | 274 | 0.060 |
Why?
|
Chemokine CCL2 | 1 | 2005 | 619 | 0.050 |
Why?
|
Protein Transport | 1 | 2008 | 1988 | 0.050 |
Why?
|
Ligaments | 2 | 1995 | 129 | 0.050 |
Why?
|
Neoplasms | 1 | 2011 | 21696 | 0.050 |
Why?
|
Serine | 1 | 2006 | 826 | 0.050 |
Why?
|
DNA, Bacterial | 2 | 2018 | 1465 | 0.050 |
Why?
|
Calcium | 1 | 2015 | 5755 | 0.050 |
Why?
|
Mycobacterium tuberculosis | 1 | 2013 | 1832 | 0.050 |
Why?
|
DNA Primers | 1 | 2006 | 2891 | 0.050 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2011 | 1186 | 0.050 |
Why?
|
Lipopolysaccharides | 1 | 2009 | 2216 | 0.050 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2021 | 130 | 0.050 |
Why?
|
Protein Isoforms | 1 | 2006 | 1730 | 0.050 |
Why?
|
Cell Line | 4 | 2015 | 16000 | 0.050 |
Why?
|
CHO Cells | 1 | 2003 | 1409 | 0.050 |
Why?
|
Epidermal Growth Factor | 1 | 2003 | 709 | 0.050 |
Why?
|
Integrin beta Chains | 1 | 2020 | 121 | 0.050 |
Why?
|
Tissue Inhibitor of Metalloproteinase-3 | 1 | 2000 | 34 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 2 | 2006 | 1988 | 0.050 |
Why?
|
Granzymes | 1 | 2021 | 271 | 0.050 |
Why?
|
Crohn Disease | 1 | 2013 | 2304 | 0.050 |
Why?
|
Enhancer Elements, Genetic | 1 | 2006 | 1340 | 0.040 |
Why?
|
Rats | 6 | 2016 | 24252 | 0.040 |
Why?
|
Male | 14 | 2021 | 350115 | 0.040 |
Why?
|
Cricetinae | 1 | 2003 | 2475 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2005 | 1000 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2006 | 10943 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2020 | 418 | 0.040 |
Why?
|
Leukocytes | 3 | 2013 | 2045 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2006 | 2204 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2011 | 2962 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2011 | 4386 | 0.040 |
Why?
|
Phagocytosis | 3 | 2011 | 1539 | 0.040 |
Why?
|
Lung Diseases, Interstitial | 1 | 2007 | 808 | 0.040 |
Why?
|
Cattle | 4 | 2004 | 3922 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 808 | 0.040 |
Why?
|
Cloning, Molecular | 3 | 2004 | 4320 | 0.040 |
Why?
|
Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2017 | 40 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2020 | 1547 | 0.040 |
Why?
|
Surface Properties | 1 | 1999 | 1184 | 0.030 |
Why?
|
Restriction Mapping | 1 | 1996 | 878 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2002 | 1005 | 0.030 |
Why?
|
Leukocyte Elastase | 1 | 1996 | 113 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2001 | 2726 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2020 | 2088 | 0.030 |
Why?
|
Female | 10 | 2021 | 380193 | 0.030 |
Why?
|
Disease Susceptibility | 3 | 2008 | 1782 | 0.030 |
Why?
|
Protein Kinase C | 2 | 2015 | 1227 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1995 | 1801 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 944 | 0.030 |
Why?
|
Enteritis | 1 | 2015 | 165 | 0.030 |
Why?
|
Germinal Center | 1 | 2017 | 377 | 0.030 |
Why?
|
Streptococcal Infections | 1 | 2018 | 638 | 0.030 |
Why?
|
ADAM Proteins | 1 | 2015 | 243 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 3873 | 0.030 |
Why?
|
Survival Rate | 1 | 2008 | 12788 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2018 | 1213 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 2008 | 821 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3338 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1073 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2017 | 598 | 0.030 |
Why?
|
Microscopy, Video | 1 | 2013 | 245 | 0.030 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2018 | 1122 | 0.030 |
Why?
|
Peptide Fragments | 3 | 2005 | 5096 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2013 | 379 | 0.030 |
Why?
|
Antibody Formation | 1 | 2017 | 1402 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2015 | 1865 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 16690 | 0.030 |
Why?
|
Hydrodynamics | 1 | 2013 | 158 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7182 | 0.020 |
Why?
|
Lanthanum | 1 | 2011 | 30 | 0.020 |
Why?
|
Base Sequence | 3 | 2001 | 12797 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2004 | 5023 | 0.020 |
Why?
|
Substrate Specificity | 1 | 1995 | 1802 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2006 | 4925 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2015 | 4424 | 0.020 |
Why?
|
Chemokine CCL5 | 1 | 2011 | 209 | 0.020 |
Why?
|
Epitopes | 1 | 2017 | 2571 | 0.020 |
Why?
|
Binding, Competitive | 1 | 1991 | 1157 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2013 | 502 | 0.020 |
Why?
|
Permeability | 1 | 2012 | 738 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1790 | 0.020 |
Why?
|
Chemokine CXCL10 | 1 | 2011 | 305 | 0.020 |
Why?
|
Antibodies | 2 | 2005 | 2460 | 0.020 |
Why?
|
Crystallization | 1 | 2011 | 525 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2013 | 1799 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2012 | 675 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2013 | 1525 | 0.020 |
Why?
|
Intestine, Small | 1 | 2015 | 1240 | 0.020 |
Why?
|
Caspases | 1 | 2012 | 928 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2013 | 1423 | 0.020 |
Why?
|
Genotype | 1 | 2003 | 12952 | 0.020 |
Why?
|
Down-Regulation | 1 | 2016 | 3001 | 0.020 |
Why?
|
Lymphocytes | 1 | 2017 | 2617 | 0.020 |
Why?
|
Angiotensin II | 1 | 2011 | 881 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4479 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2008 | 370 | 0.020 |
Why?
|
Models, Biological | 2 | 2016 | 9584 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2011 | 2646 | 0.020 |
Why?
|
Secretory Vesicles | 1 | 2008 | 124 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2017 | 3203 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4222 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5882 | 0.020 |
Why?
|
Cadherins | 1 | 2011 | 907 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2013 | 3144 | 0.020 |
Why?
|
Mammals | 1 | 1991 | 1143 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2011 | 1438 | 0.020 |
Why?
|
Liver | 2 | 2020 | 7475 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5172 | 0.020 |
Why?
|
Rats, Inbred BN | 1 | 2005 | 235 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2013 | 2700 | 0.020 |
Why?
|
Cell Migration Inhibition | 1 | 2005 | 96 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2017 | 1736 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4751 | 0.020 |
Why?
|
Zebrafish | 1 | 2017 | 2996 | 0.020 |
Why?
|
Antigens, Fungal | 1 | 2005 | 70 | 0.020 |
Why?
|
Models, Animal | 1 | 2011 | 2173 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2013 | 12961 | 0.020 |
Why?
|
Peroxidase | 1 | 2008 | 611 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 1991 | 1423 | 0.020 |
Why?
|
Cell Division | 1 | 2012 | 4569 | 0.020 |
Why?
|
Receptors, CCR2 | 1 | 2005 | 212 | 0.020 |
Why?
|
Macrophages, Peritoneal | 1 | 2005 | 251 | 0.020 |
Why?
|
Chemokines, CC | 1 | 2005 | 291 | 0.010 |
Why?
|
Muscle Development | 1 | 2006 | 271 | 0.010 |
Why?
|
Aspergillus fumigatus | 1 | 2005 | 150 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16367 | 0.010 |
Why?
|
Islets of Langerhans Transplantation | 1 | 1989 | 745 | 0.010 |
Why?
|
Antigen-Antibody Complex | 1 | 2005 | 517 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2011 | 2765 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 2076 | 0.010 |
Why?
|
Ovalbumin | 1 | 2005 | 719 | 0.010 |
Why?
|
Intestines | 1 | 2012 | 1924 | 0.010 |
Why?
|
Cell Count | 1 | 2007 | 1856 | 0.010 |
Why?
|
Cytoplasm | 2 | 2001 | 1536 | 0.010 |
Why?
|
Kidney | 3 | 2007 | 7184 | 0.010 |
Why?
|
Chemotaxis | 1 | 2005 | 607 | 0.010 |
Why?
|
Receptors, Chemokine | 1 | 2005 | 670 | 0.010 |
Why?
|
Rare Diseases | 1 | 2007 | 553 | 0.010 |
Why?
|
Bleomycin | 1 | 2002 | 512 | 0.010 |
Why?
|
Interleukin-4 | 1 | 2005 | 1147 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2007 | 1641 | 0.010 |
Why?
|
Time Factors | 3 | 2011 | 40075 | 0.010 |
Why?
|
Antigens, CD | 1 | 2011 | 4026 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2013 | 13035 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6539 | 0.010 |
Why?
|
Th2 Cells | 1 | 2005 | 1061 | 0.010 |
Why?
|
Blood Vessels | 1 | 2005 | 1125 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2011 | 8300 | 0.010 |
Why?
|
Hot Temperature | 1 | 2005 | 1356 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2002 | 675 | 0.010 |
Why?
|
Receptors, Thrombin | 1 | 2000 | 131 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2008 | 3207 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 2000 | 683 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2013 | 39052 | 0.010 |
Why?
|
Cell Wall | 1 | 2001 | 422 | 0.010 |
Why?
|
Fibrosis | 1 | 2005 | 2029 | 0.010 |
Why?
|
Graft Survival | 1 | 1989 | 3737 | 0.010 |
Why?
|
Biological Transport | 1 | 2002 | 2120 | 0.010 |
Why?
|
Wnt Proteins | 1 | 2002 | 721 | 0.010 |
Why?
|
Liver Transplantation | 1 | 1989 | 2119 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13693 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2002 | 1549 | 0.010 |
Why?
|
Macrophages | 1 | 2011 | 5660 | 0.010 |
Why?
|
Hydroxamic Acids | 1 | 2000 | 494 | 0.010 |
Why?
|
Aorta | 1 | 2004 | 2062 | 0.010 |
Why?
|
Adult | 3 | 2016 | 214052 | 0.010 |
Why?
|
Blood Pressure | 1 | 2011 | 8551 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2007 | 3476 | 0.010 |
Why?
|
Rabbits | 1 | 2001 | 4894 | 0.010 |
Why?
|
Infant | 1 | 2017 | 35134 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 1284 | 0.010 |
Why?
|
Drosophila | 1 | 2002 | 1491 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 41005 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2000 | 3702 | 0.010 |
Why?
|
Escherichia coli | 1 | 2005 | 4217 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 3773 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2000 | 1525 | 0.010 |
Why?
|
Anticoagulants | 1 | 2008 | 4600 | 0.010 |
Why?
|
Prognosis | 1 | 2013 | 29060 | 0.010 |
Why?
|
Acute Disease | 1 | 2002 | 7147 | 0.010 |
Why?
|
Peptides | 1 | 2004 | 4410 | 0.010 |
Why?
|
Receptors, Laminin | 1 | 1991 | 26 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 1991 | 184 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2000 | 2455 | 0.010 |
Why?
|
Disease Progression | 1 | 2007 | 13286 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2002 | 3188 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2002 | 4554 | 0.010 |
Why?
|
Laminin | 1 | 1991 | 419 | 0.010 |
Why?
|
Rats, Inbred WF | 1 | 1989 | 140 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1991 | 1375 | 0.010 |
Why?
|
Solubility | 1 | 1991 | 1088 | 0.010 |
Why?
|
Cyclosporins | 1 | 1989 | 220 | 0.010 |
Why?
|
Transplantation, Isogeneic | 1 | 1989 | 257 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2007 | 15535 | 0.010 |
Why?
|
Culture Media | 1 | 1991 | 909 | 0.010 |
Why?
|
Molecular Weight | 1 | 1991 | 2255 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1991 | 1095 | 0.010 |
Why?
|
Cohort Studies | 1 | 2011 | 40559 | 0.010 |
Why?
|
Middle Aged | 2 | 2016 | 213390 | 0.000 |
Why?
|
Blood | 1 | 1991 | 598 | 0.000 |
Why?
|
Gene Library | 1 | 1991 | 1074 | 0.000 |
Why?
|
Hypertension | 1 | 2008 | 8479 | 0.000 |
Why?
|
Histocompatibility Antigens | 1 | 1989 | 471 | 0.000 |
Why?
|
Rats, Inbred Lew | 1 | 1989 | 1162 | 0.000 |
Why?
|
Immunoassay | 1 | 1991 | 752 | 0.000 |
Why?
|
Transplantation Immunology | 1 | 1989 | 546 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2007 | 20130 | 0.000 |
Why?
|
Islets of Langerhans | 1 | 1989 | 1352 | 0.000 |
Why?
|
Obesity | 1 | 2002 | 12746 | 0.000 |
Why?
|